Multiomics analysis of homologous recombination deficiency across cancer types
2024

Multiomics Analysis of Homologous Recombination Deficiency Across Cancer Types

Sample size: 33 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dong Lin, Li Lin, Zhu Linyan, Xu Fei, Zhang Rumeng, Li Qiushuang, Zhu Yong, Zeng Zhutian, Ding Keshuo

Primary Institution: Anhui Medical University

Hypothesis

The study investigates the association of homologous recombination deficiency (HRD) with patient survival across various malignancies.

Conclusion

HRD is significantly associated with patient prognosis, but its impact varies among different cancer types.

Supporting Evidence

  • HRD was found to be significantly associated with patient prognosis across 23 cancer types.
  • High HRD levels correlated with lower overall survival rates in many cancers.
  • Driver gene mutations were associated with HRD across specific cancer types.

Takeaway

This study looks at how a problem in DNA repair, called homologous recombination deficiency, affects cancer patients differently depending on their cancer type.

Methodology

The study conducted a multivariable omics analysis on HRD in 33 cancer types, focusing on patient prognosis, gene expression, gene mutation, and signaling pathways.

Limitations

The study primarily focuses on 23 cancers with significant associations, which may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.17305/bb.2024.10448

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication